Search - tctmd.com

Displaying 501 - 520 of 918

Sort: Relevancy | Date

Polymer-Free BioFreedom Stent as Safe as Orsiro, but Not as Effective

News Conference News TCT 2018

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Michael O'Riordan

September 22, 2018

Presentation TCT 2018

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

Presenter: C. Michael Gibson, William H. Maisel, Peter J. Fitzgerald

September 22, 2018

News Conference News TCT 2018

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

Yael L. Maxwell

September 22, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Shelley Wood

September 11, 2018

News Conference News PCR London Valves 2018

Clips and Rings for Tricuspid Regurgitation: Early Data Speak to Progress and Challenges

Shelley Wood

September 10, 2018

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Industry News

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

August 14, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

News Opinion Fellow Talk

Finding Your Niche in Medicine: Not a Straight Path

Ankur Gupta, MD, PhD

August 10, 2018

News Daily News

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Michael O'Riordan

August 09, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Daily News

Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention?

Todd Neale

July 20, 2018

News Opinion Fellow Talk

Is Your Interventional Career the Scourge of Your Musculoskeletal System?

Mesfer Alfadhel, MD

July 18, 2018

News Opinion Fellow Talk

Introducing the 2018-2019 Fellow Talk Bloggers

Yael L. Maxwell

July 11, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

L.A. McKeown

July 03, 2018

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

Todd Neale

July 02, 2018

Advertisement

CORRECTION: Polymer-Free BioFreedom Stent Faces Off Against Orsiro

Keynote Lecture: The Potential Impact of Machine Learning/Artificial Intelligence on Cardiovascular Medical Device Development

The End of BMS? LEADERS FREE II Shows Superiority of Polymer-Free, Drug-Coated Stent

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Clips and Rings for Tricuspid Regurgitation: Early Data Speak to Progress and Challenges

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Finding Your Niche in Medicine: Not a Straight Path

Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Is Weight-Based Dosing of Aspirin Needed for Effective Primary Prevention?

Is Your Interventional Career the Scourge of Your Musculoskeletal System?

Introducing the 2018-2019 Fellow Talk Bloggers

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content